William Blair analyst Andy Hsieh, reiterated an Outperform rating on Viking Therapeutic (NASDAQ: VKTX) after the company announced that the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE